mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.07 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.11 |
0.07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.07 |